Literature DB >> 11139163

Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever?

E S de Bont, E Vellenga, J Swaanenburg, W Kamps.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11139163     DOI: 10.1007/s150100070014

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  11 in total

1.  Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer.

Authors:  L Kitanovski; J Jazbec; S Hojker; M Gubina; M Derganc
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

2.  Procalcitonin in febrile neutropenia--timing is important.

Authors:  Ban Hock Tan; May Ee Png; Chin Pin Yeo; Gee Chuan Wong
Journal:  Support Care Cancer       Date:  2013-12-04       Impact factor: 3.603

Review 3.  Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis.

Authors:  Chun-Wei Wu; Jiunn-Yih Wu; Chun-Kuei Chen; Shiau-Ling Huang; Shou-Chien Hsu; Meng-Tse Gabriel Lee; Shy-Shin Chang; Chien-Chang Lee
Journal:  Support Care Cancer       Date:  2015-02-21       Impact factor: 3.603

Review 4.  Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Authors:  Mirjam Christ-Crain; Steven M Opal
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

5.  Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.

Authors:  Claudi S M Oude Nijhuis; Edo Vellenga; Simon M G J Daenen; Winette T A van der Graaf; Jourik A Gietema; Harry J M Groen; Willem A Kamps; Eveline S J M de Bont
Journal:  Intensive Care Med       Date:  2003-10-16       Impact factor: 17.440

6.  Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.

Authors:  M von Lilienfeld-Toal; M P Dietrich; A Glasmacher; L Lehmann; P Breig; C Hahn; I G H Schmidt-Wolf; G Marklein; S Schroeder; F Stuber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-22       Impact factor: 3.267

7.  VCS parameters of neutrophils, monocytes and lymphocytes may indicate local bacterial infection in cancer patients who accepted cytotoxic chemotherapeutics.

Authors:  N Zhou; L Liu; D Li; Q Zeng; X Song
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-12       Impact factor: 3.267

8.  Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients.

Authors:  Letícia Carvalho Neuenschwander; Henrique Bittencourt; Ana Flávia Tibúrcio Ribeiro; Antônio Lúcio Teixeira; Mauro M Teixeira; Jairo Cerqueira Teixeira; Vandack Nobre
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients.

Authors:  Amanda G Blouin; Meier Hsu; Martin Fleisher; Lakshmi V Ramanathan; Stephen M Pastores
Journal:  Clin Chim Acta       Date:  2020-07-15       Impact factor: 3.786

10.  Procalcitonin and C-reactive protein in differantiating to contamination from bacteremia.

Authors:  Lutfiye Oksuz; Ayper Somer; Nuran Salman; Osman Erk; Nezahat Gurler
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.